Horizon Discovery Group PLC (HZD) Earns “Buy” Rating from Numis Securities Ltd
Horizon Discovery Group PLC (LON:HZD)‘s stock had its “buy” rating reissued by investment analysts at Numis Securities Ltd in a report released on Friday. They presently have a GBX 300 ($3.87) price objective on the stock. Numis Securities Ltd’s price objective points to a potential upside of 26.05% from the company’s previous close.
Several other equities analysts have also recently commented on the stock. Royal Bank Of Canada lifted their target price on shares of Horizon Discovery Group PLC from GBX 220 ($2.84) to GBX 245 ($3.16) and gave the stock a “speculative buy” rating in a research report on Thursday, July 20th. Shore Capital reaffirmed a “not rated” rating on shares of Horizon Discovery Group PLC in a report on Wednesday, July 19th. N+1 Singer lifted their price target on shares of Horizon Discovery Group PLC from GBX 194 ($2.51) to GBX 219 ($2.83) and gave the stock a “buy” rating in a report on Thursday, June 15th. Beaufort Securities reaffirmed a “speculative buy” rating and issued a GBX 200 ($2.58) price target on shares of Horizon Discovery Group PLC in a report on Wednesday, May 31st. Finally, Panmure Gordon reaffirmed a “buy” rating and issued a GBX 205 ($2.65) price target on shares of Horizon Discovery Group PLC in a report on Monday, May 22nd. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus price target of GBX 233.80 ($3.02).
Shares of Horizon Discovery Group PLC (HZD) remained flat at GBX 238.00 during trading on Friday. The company had a trading volume of 5,000 shares. The company has a 50 day moving average of GBX 257.84 and a 200 day moving average of GBX 209.93. The stock’s market capitalization is GBX 226.68 million. Horizon Discovery Group PLC has a 12-month low of GBX 104.00 and a 12-month high of GBX 297.70.
TRADEMARK VIOLATION WARNING: This piece of content was first published by American Banking News and is the sole property of of American Banking News. If you are reading this piece of content on another site, it was stolen and reposted in violation of US & international trademark & copyright legislation. The legal version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/09/09/horizon-discovery-group-plc-hzd-earns-buy-rating-from-numis-securities-ltd.html.
Horizon Discovery Group PLC Company Profile
Horizon Discovery Group PLC is a gene editing company that designs and engineers genetically-modified cells, applying them in research and clinical applications to advance human health. The Company’s gene editing platform, able to alter almost any gene sequence, has generated a catalogue of over 23,000 cell and in vivo models that recapitulate the genetic anomalies found in diseases like cancer.
Receive News & Ratings for Horizon Discovery Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Horizon Discovery Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.